These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 27862289)

  • 1. Insulin resistance and the risk of hepatocellular carcinoma in chronic hepatitis B patients.
    Kim JH; Sinn DH; Gwak GY; Kang W; Paik YH; Choi MS; Lee JH; Koh KC; Paik SW
    J Gastroenterol Hepatol; 2017 May; 32(5):1100-1106. PubMed ID: 27862289
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Liver stiffness-based optimization of hepatocellular carcinoma risk score in patients with chronic hepatitis B.
    Wong GL; Chan HL; Wong CK; Leung C; Chan CY; Ho PP; Chung VC; Chan ZC; Tse YK; Chim AM; Lau TK; Wong VW
    J Hepatol; 2014 Feb; 60(2):339-45. PubMed ID: 24128413
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of Metabolic Risk Factors on Risk of Hepatocellular Carcinoma and Liver-Related Death in Men With Chronic Hepatitis B: A Large Cohort Study.
    Yu MW; Lin CL; Liu CJ; Yang SH; Tseng YL; Wu CF
    Gastroenterology; 2017 Oct; 153(4):1006-1017.e5. PubMed ID: 28711626
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Concurrent fatty liver increases risk of hepatocellular carcinoma among patients with chronic hepatitis B.
    Chan AW; Wong GL; Chan HY; Tong JH; Yu YH; Choi PC; Chan HL; To KF; Wong VW
    J Gastroenterol Hepatol; 2017 Mar; 32(3):667-676. PubMed ID: 27547913
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insulin resistance is associated with hepatocellular carcinoma in chronic hepatitis C infection.
    Hung CH; Wang JH; Hu TH; Chen CH; Chang KC; Yen YH; Kuo YH; Tsai MC; Lu SN; Lee CM
    World J Gastroenterol; 2010 May; 16(18):2265-71. PubMed ID: 20458764
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High levels of hepatitis B surface antigen increase risk of hepatocellular carcinoma in patients with low HBV load.
    Tseng TC; Liu CJ; Yang HC; Su TH; Wang CC; Chen CL; Kuo SF; Liu CH; Chen PJ; Chen DS; Kao JH
    Gastroenterology; 2012 May; 142(5):1140-1149.e3; quiz e13-4. PubMed ID: 22333950
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genotype C hepatitis B virus infection is associated with an increased risk of hepatocellular carcinoma.
    Chan HL; Hui AY; Wong ML; Tse AM; Hung LC; Wong VW; Sung JJ
    Gut; 2004 Oct; 53(10):1494-8. PubMed ID: 15361502
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Obesity and hepatocellular carcinoma in patients receiving entecavir for chronic hepatitis B.
    Lee J; Yoo SH; Sohn W; Kim HW; Choi YS; Won JH; Heo JY; Park SJ; Park YM
    Clin Mol Hepatol; 2016 Sep; 22(3):339-349. PubMed ID: 27729627
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Virological suppression does not prevent the development of hepatocellular carcinoma in HBeAg-negative chronic hepatitis B patients with cirrhosis receiving oral antiviral(s) starting with lamivudine monotherapy: results of the nationwide HEPNET. Greece cohort study.
    Papatheodoridis GV; Manolakopoulos S; Touloumi G; Vourli G; Raptopoulou-Gigi M; Vafiadis-Zoumbouli I; Vasiliadis T; Mimidis K; Gogos C; Ketikoglou I; Manesis EK;
    Gut; 2011 Aug; 60(8):1109-16. PubMed ID: 21270118
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Coexistence of hepatitis B surface antigen and antibody to hepatitis B surface may increase the risk of hepatocellular carcinoma in chronic hepatitis B virus infection: a retrospective cohort study.
    Seo SI; Choi HS; Choi BY; Kim HS; Kim HY; Jang MK
    J Med Virol; 2014 Jan; 86(1):124-30. PubMed ID: 24127328
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incorporating Serum Level of Hepatitis B Surface Antigen or Omitting Level of Hepatitis B Virus DNA Does not Affect Calculation of Risk for Hepatocellular Carcinoma in Patients Without Cirrhosis.
    Yang HI; Tseng TC; Liu J; Lee MH; Liu CJ; Su TH; Batrla-Utermann R; Chan HL; Kao JH; Chen CJ
    Clin Gastroenterol Hepatol; 2016 Mar; 14(3):461-468.e2. PubMed ID: 26598229
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Incidence of hepatocellular carcinoma after HBsAg seroclearance in chronic hepatitis B patients: a need for surveillance.
    Kim GA; Lee HC; Kim MJ; Ha Y; Park EJ; An J; Lee D; Shim JH; Kim KM; Lim YS
    J Hepatol; 2015 May; 62(5):1092-9. PubMed ID: 25445399
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Influence of Metabolic Syndrome on the Risk of Hepatocellular Carcinoma in Patients with Chronic Hepatitis B Infection in Mainland China.
    Tan Y; Zhang X; Zhang W; Tang L; Yang H; Yan K; Jiang L; Yang J; Li C; Yang J; Wen T; Tang H; Yan L
    Cancer Epidemiol Biomarkers Prev; 2019 Dec; 28(12):2038-2046. PubMed ID: 31533942
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cut-off points of homeostasis model assessment of insulin resistance, beta-cell function, and fasting serum insulin to identify future type 2 diabetes: Tehran Lipid and Glucose Study.
    Ghasemi A; Tohidi M; Derakhshan A; Hasheminia M; Azizi F; Hadaegh F
    Acta Diabetol; 2015 Oct; 52(5):905-15. PubMed ID: 25794879
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Type 2 diabetes and hepatocellular carcinoma: a case-control study in patients with chronic hepatitis B.
    Li Q; Li WW; Yang X; Fan WB; Yu JH; Xie SS; Liu L; Ma LX; Chen SJ; Kato N
    Int J Cancer; 2012 Sep; 131(5):1197-202. PubMed ID: 22052244
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High liver fibrosis index FIB-4 is highly predictive of hepatocellular carcinoma in chronic hepatitis B carriers.
    Suh B; Park S; Shin DW; Yun JM; Yang HK; Yu SJ; Shin CI; Kim JS; Ahn E; Lee H; Park JH; Cho B
    Hepatology; 2015 Apr; 61(4):1261-8. PubMed ID: 25502481
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatitis B virus reactivation after radiofrequency ablation or hepatic resection for HBV-related small hepatocellular carcinoma: a retrospective study.
    Dan JQ; Zhang YJ; Huang JT; Chen MS; Gao HJ; Peng ZW; Xu L; Lau WY
    Eur J Surg Oncol; 2013 Aug; 39(8):865-72. PubMed ID: 23597497
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of Daily Aspirin Therapy With Risk of Hepatocellular Carcinoma in Patients With Chronic Hepatitis B.
    Lee TY; Hsu YC; Tseng HC; Yu SH; Lin JT; Wu MS; Wu CY
    JAMA Intern Med; 2019 May; 179(5):633-640. PubMed ID: 30882847
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diabetes Mellitus is a Risk Factor for Hepatocellular Carcinoma in Patients with Chronic Hepatitis B Virus Infection in China.
    Li X; Xu H; Gao P
    Med Sci Monit; 2018 Sep; 24():6729-6734. PubMed ID: 30245503
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of occult hepatitis B virus infection on the outcome of chronic hepatitis C.
    Squadrito G; Cacciola I; Alibrandi A; Pollicino T; Raimondo G
    J Hepatol; 2013 Oct; 59(4):696-700. PubMed ID: 23751755
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.